Skip to content

Poll Finds Patient Safety is Threatened by Current Ultrasound-Guided PIV Insertion Techniques

New findings highlight the urgent need to reduce contamination riskthrough standardized, aseptic non-touch technique HARTWELL, Georgia. – A new clinician poll conducted by Nancy Moureau, RN, PhD, CRNI, CPUI, VA-BC, has found that relatively few healthcare facilities have established a standardized process for maintaining proper aseptic non-touch technique during ultrasound-guided peripheral IV (UGPIV) insertion. TheContinue reading “Poll Finds Patient Safety is Threatened by Current Ultrasound-Guided PIV Insertion Techniques”

UltraDrape® Barrier & Securement Dressing from Parker Laboratories Obtains CE Mark

Innovative technology for ultrasound-guided IV insertions improves patient safety and lowers costs FAIRFIELD, New Jersey — Parker Laboratories, a worldwide leader in ultrasound products for more than 60 years, announced it has obtained the CE mark for UltraDrape™, the first combination sterile barrier and securement dressing for ultrasound-guided peripheral intravenous (UGPIV) insertions. UltraDrape was developedContinue reading “UltraDrape® Barrier & Securement Dressing from Parker Laboratories Obtains CE Mark”

Parker Laboratories Introduces World’s First UGPIV Barrier and Securement Dressing

Fairfield, New Jersey — Parker Laboratories, Inc. announces the launch of UltraDrape™UGPIV Barrier and Securement, the first-of-its-kind, uniquely designed dressing for use during Ultrasound-Guided Peripheral Intravenous (UGPIV) procedures. The dual-action dressing was engineered to address the challenges that often arise with UGPIV such as: extended procedure times, securement failure – a result of inadequate gelContinue reading “Parker Laboratories Introduces World’s First UGPIV Barrier and Securement Dressing”

World’s Ultrasound and Electromedical Industry Leader Celebrates 60th Anniversary

Fairfield, New Jersey – For Parker Laboratories, Inc., the world leader in the development, manufacturing and marketing of medical ultrasound and electromedical products, 2018 marks 60 years of commitment to the advancement of healthcare and the medical ultrasound industry. Since its development and introduction of the first medical ultrasound gel, Aquasonic® 100 in 1958, ParkerContinue reading “World’s Ultrasound and Electromedical Industry Leader Celebrates 60th Anniversary”

Medical Ultrasound Pioneer Expands New Jersey-Based Facilities

Fairfield, New Jersey – Medical ultrasound global leader Parker Laboratories, Inc. announces the relocation of its corporate offices and finished goods warehousing to 4 Sperry Road, while current manufacturing facilities are expanded at 286 Eldridge Road, both slated for completion in January 2018. The move and expansion increases Parker’s footprint from its current 40,000 sq.Continue reading “Medical Ultrasound Pioneer Expands New Jersey-Based Facilities”

Parker Laboratories Unrelated to NJ Medical Device Manufacturer in Contaminated Ultrasound Gel Case

Ultrasound Gel Leader, Parker Laboratories, distances itself from Pharmaceutical Innovations guilty plea in U.S. District Court. Parker Laboratories stringent quality assurance procedures include comprehensive environmental monitoring and continual microbial testing to provide healthcare professionals and patients alike with market-best products for nearly 60 years. According to Neal Buchalter, President, Parker Laboratories, “We ensure product qualityContinue reading “Parker Laboratories Unrelated to NJ Medical Device Manufacturer in Contaminated Ultrasound Gel Case”

Honorary Doctor of Science Degree Conferred to Martin Buchalter, Founder, Parker Laboratories, Inc.

Thursday, February 19, 2015 The University of the Sciences, Philadelphia, PA, confered the Honorary Doctor of Science Degree upon Martin Buchalter, MS, founder of Parker Laboratories, Inc. The award was accepted by Carol Buchalter, wife and Board Chairman of Parker Laboratories, Inc. When Martin Buchalter graduated from Philadelphia College of Pharmacy and Science in 1955,Continue reading “Honorary Doctor of Science Degree Conferred to Martin Buchalter, Founder, Parker Laboratories, Inc.”

CDC Deems Protex® and Protex® ULTRA Suitable for Use in Suspected or Confirmed Cases of Ebola Virus Infection

Fairfield, New Jersey, – Protex™ Disinfectant Spray and Wipes and Protex ULTRA Disinfectant Wipes, efficacious against rotavirus, are EPA-registered hospital disinfectants. According to CDC guidance, this product can be used to disinfect environmental surfaces in rooms of patients with suspected or confirmed Ebola virus infection. Protex products are suitable for use in the cleaning andContinue reading “CDC Deems Protex® and Protex® ULTRA Suitable for Use in Suspected or Confirmed Cases of Ebola Virus Infection”

Parker Laboratories Introduces Protex® ULTRA with Faster Kill Times and Expanded Pathogen Effectiveness

Fairfield, New Jersey – Parker Laboratories, the world-leading manufacturer of ultrasound and electromedical contact media, announces the arrival of new Protex ULTRA Disinfectant Wipes. With its new formulation, Protex ULTRA will eliminate 99.9% of bacteria in 15 seconds and disinfects in just 4 minutes. 6.5” x 6.0” non-abrasive wipes are safe for most hard surfacesContinue reading “Parker Laboratories Introduces Protex® ULTRA with Faster Kill Times and Expanded Pathogen Effectiveness”